Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2018

12.09.2018 | Preclinical study

Labour productivity loss caused by premature deaths associated with breast cancer: results from Spain over a 10-year period

verfasst von: J. Oliva-Moreno, L. M. Peña-Longobardo

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Breast cancer is one of the most common cancers among women worldwide, and is the most common cause of cancer deaths in them. Given that such disease has a significant impact on middle-aged women, it can result in considerable labour productivity losses. The main objective of this study is therefore to analyse labour productivity losses and years of potential working life lost as a result of premature deaths from breast cancer in Spain over a 10-year period (2005–2014).

Method

To this end, by combining data on average salary (Salary Structure Survey), occupation (Active Population Survey) and deaths (death registration according to cause of death), a simulation model based on the human capital approach was constructed to estimate productivity losses associated with premature deaths caused by this disease.

Results

The results reveal that labour productivity losses in women are estimated to cost 2,137 million euros, as a result of the 22,716 deaths occurring during working age and the 292,848 years of potential productive life lost. This implies that breast cancer is responsible for 10.45% of all estimated female labour productivity losses caused by premature deaths in the reference year.

Conclusion

The article concludes by highlighting the major economic impact associated with breast cancer deaths and by pointing out future research areas.
Literatur
2.
Zurück zum Zitat Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C et al (2015) The global burden of cancer 2013. JAMA Oncol 1(4):505–527CrossRef Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C et al (2015) The global burden of cancer 2013. JAMA Oncol 1(4):505–527CrossRef
3.
Zurück zum Zitat Cabanes A, Vidal E, Aragonés N, Pérez-Gómez B, Pollán M, Lope V, López-Abente G (2010) Cancer mortality trends in Spain: 1980–2007. Ann Oncol 21(Suppl 3):iii14–i20PubMed Cabanes A, Vidal E, Aragonés N, Pérez-Gómez B, Pollán M, Lope V, López-Abente G (2010) Cancer mortality trends in Spain: 1980–2007. Ann Oncol 21(Suppl 3):iii14–i20PubMed
4.
Zurück zum Zitat Broekx S, Den Hond E, Torfs R, Remacle A, Mertens R, D’Hooghe T, Neven P, Christiaens MR, Simoens S (2011) The costs of breast cancer prior to and following diagnosis. Eur J Health Econ 12(4):311–317CrossRef Broekx S, Den Hond E, Torfs R, Remacle A, Mertens R, D’Hooghe T, Neven P, Christiaens MR, Simoens S (2011) The costs of breast cancer prior to and following diagnosis. Eur J Health Econ 12(4):311–317CrossRef
5.
Zurück zum Zitat Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ (2010) The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat 119(1):213–220CrossRef Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ (2010) The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat 119(1):213–220CrossRef
6.
Zurück zum Zitat Drolet M, Maunsell E, Mondor M, Brisson C, Brisson J, Mâsse B, Deschênes L (2005) Work absence after breast cancer diagnosis: a population-based study. CMAJ 27(7):765–771 173(CrossRef Drolet M, Maunsell E, Mondor M, Brisson C, Brisson J, Mâsse B, Deschênes L (2005) Work absence after breast cancer diagnosis: a population-based study. CMAJ 27(7):765–771 173(CrossRef
7.
Zurück zum Zitat Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14(12):1165–1174CrossRef Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14(12):1165–1174CrossRef
8.
Zurück zum Zitat Oliva-Moreno J (2012) Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy? Eur J Health Econ 13(5):605–614CrossRef Oliva-Moreno J (2012) Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy? Eur J Health Econ 13(5):605–614CrossRef
9.
Zurück zum Zitat Grossman M (1972) The demand for health: a theoretical and empirical investigation. Columbia University Press, New York Grossman M (1972) The demand for health: a theoretical and empirical investigation. Columbia University Press, New York
10.
Zurück zum Zitat Grossman M ( 2000) The human capital model of the demand for health. In: Culyer AJ, Newhouse JP (eds.). Handbook of health economics. Elsevier, Boston. Grossman M ( 2000) The human capital model of the demand for health. In: Culyer AJ, Newhouse JP (eds.). Handbook of health economics. Elsevier, Boston.
15.
Zurück zum Zitat López-Bastida J, Oliva J, Antoñanzas F, García-Altés A, Gisbert R, Mar J, Puig-Junoy J (2010) Spanish recommendations on economic evaluation of health technologies. Eur J Health Econ 11(5):513–520CrossRef López-Bastida J, Oliva J, Antoñanzas F, García-Altés A, Gisbert R, Mar J, Puig-Junoy J (2010) Spanish recommendations on economic evaluation of health technologies. Eur J Health Econ 11(5):513–520CrossRef
17.
Zurück zum Zitat Hanly PA, Sharp L (2014) The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer 14:224CrossRef Hanly PA, Sharp L (2014) The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer 14:224CrossRef
18.
Zurück zum Zitat Hanly A, Soerjomataram I, Sharp L (2015) Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer 136(4):E136–E145CrossRef Hanly A, Soerjomataram I, Sharp L (2015) Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer 136(4):E136–E145CrossRef
19.
Zurück zum Zitat Bradley CJ, Bednarek HL, Neumark D (2002) Breast cancer survival, work, and earnings. J Health Econ 21(5):757–779CrossRef Bradley CJ, Bednarek HL, Neumark D (2002) Breast cancer survival, work, and earnings. J Health Econ 21(5):757–779CrossRef
20.
Zurück zum Zitat Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML (2008) Productivity costs of cancer mortality in the United States: 2000–2020. J Natl Cancer Inst 17(24):1763–1770 100(CrossRef Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML (2008) Productivity costs of cancer mortality in the United States: 2000–2020. J Natl Cancer Inst 17(24):1763–1770 100(CrossRef
21.
Zurück zum Zitat Max W, Sung HY, Stark B (2009) The economic burden of breast cancer in California. Breast Cancer Res Treat 116(1):201–207CrossRef Max W, Sung HY, Stark B (2009) The economic burden of breast cancer in California. Breast Cancer Res Treat 116(1):201–207CrossRef
23.
Zurück zum Zitat Zheng Z, Yabroff KR, Guy GP Jr, Han X, Li C, Banegas MP, Ekwueme DU, Jemal A: Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States. JNCI J Natl Cancer Inst. 2016; 108(5)CrossRef Zheng Z, Yabroff KR, Guy GP Jr, Han X, Li C, Banegas MP, Ekwueme DU, Jemal A: Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States. JNCI J Natl Cancer Inst. 2016; 108(5)CrossRef
24.
Zurück zum Zitat Hanly P, Timmons A, Walsh PM, Sharp L (2012) Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health 15(3):429–436CrossRef Hanly P, Timmons A, Walsh PM, Sharp L (2012) Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health 15(3):429–436CrossRef
25.
Zurück zum Zitat Ekwueme DU, Guy GP Jr, Rim SH, White A, Hall IJ, Fairley TL, Dean HD (2014) Health and economic impact of breast cancer mortality in young women, 1970–2008. Am J Prev Med 46(1):71–79CrossRef Ekwueme DU, Guy GP Jr, Rim SH, White A, Hall IJ, Fairley TL, Dean HD (2014) Health and economic impact of breast cancer mortality in young women, 1970–2008. Am J Prev Med 46(1):71–79CrossRef
26.
Zurück zum Zitat Łyszczarz B, Nojszewska E (2017) Productivity losses and public finance burden attributable to breast cancer in Poland, 2010–2014. BMC Cancer 17(1):676CrossRef Łyszczarz B, Nojszewska E (2017) Productivity losses and public finance burden attributable to breast cancer in Poland, 2010–2014. BMC Cancer 17(1):676CrossRef
27.
Zurück zum Zitat Carter HE, Schofield DJ, Shrestha R: The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model. PLoS ONE. 2016; 11(12)CrossRef Carter HE, Schofield DJ, Shrestha R: The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model. PLoS ONE. 2016; 11(12)CrossRef
28.
Zurück zum Zitat Pearce A, Bradley C, Hanly P, O’Neill C, Thomas AA, Molcho M, Sharp L (2016) Projecting productivity losses for cancer-related mortality 2011–2030. BMC Cancer 16(1):804CrossRef Pearce A, Bradley C, Hanly P, O’Neill C, Thomas AA, Molcho M, Sharp L (2016) Projecting productivity losses for cancer-related mortality 2011–2030. BMC Cancer 16(1):804CrossRef
29.
Zurück zum Zitat Oliva J, Lobo F, López-Bastida J, Zozaya N, Romay R (2005) Indirect costs of cervical and breast cancers in Spain. Eur J Health Econ 6(4):309–313CrossRef Oliva J, Lobo F, López-Bastida J, Zozaya N, Romay R (2005) Indirect costs of cervical and breast cancers in Spain. Eur J Health Econ 6(4):309–313CrossRef
30.
Zurück zum Zitat Peña-Longobardo LM, Aranda-Reneo I, Oliva-Moreno J, Val-Castello J (2015) Pérdidas laborales ocasionadas por muertes prematuras en España: Un análisis para el periodo 2005–2009. Rev Esp Salud Pública 89:39–50CrossRef Peña-Longobardo LM, Aranda-Reneo I, Oliva-Moreno J, Val-Castello J (2015) Pérdidas laborales ocasionadas por muertes prematuras en España: Un análisis para el periodo 2005–2009. Rev Esp Salud Pública 89:39–50CrossRef
31.
Zurück zum Zitat Vicente-Herrero MT, Terradillos-García MJ, Ramírez-Iñiguez de la Torre, MV, Capdevila-García LM, Aguilar-Jiménez E, López-González AA (2012) El cáncer de mama en España. Aproximación a su coste económico por incapacidad temporal durante 2010. GAMO 11:351–357 Vicente-Herrero MT, Terradillos-García MJ, Ramírez-Iñiguez de la Torre, MV, Capdevila-García LM, Aguilar-Jiménez E, López-González AA (2012) El cáncer de mama en España. Aproximación a su coste económico por incapacidad temporal durante 2010. GAMO 11:351–357
32.
Zurück zum Zitat Lidgren M, Wilking N, Jönsson B, Rehnberg C (2007) Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care 23(2):223–231CrossRef Lidgren M, Wilking N, Jönsson B, Rehnberg C (2007) Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care 23(2):223–231CrossRef
33.
Zurück zum Zitat Yabroff KR, Kim Y (2009) Time costs associated with informal caregiving for cancer survivors. Cancer 115(18):4362–4373CrossRef Yabroff KR, Kim Y (2009) Time costs associated with informal caregiving for cancer survivors. Cancer 115(18):4362–4373CrossRef
34.
Zurück zum Zitat Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA (2016) Economic Burden of Bladder Cancer Across the European Union. Eur Urol 69(3):438–447 (2016)CrossRef Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA (2016) Economic Burden of Bladder Cancer Across the European Union. Eur Urol 69(3):438–447 (2016)CrossRef
35.
Zurück zum Zitat Round J, Jones L, Morris S (2015) Estimating the cost of caring for people with cancer at the end of life: A modelling study. Palliat Med 29(10):899–907CrossRef Round J, Jones L, Morris S (2015) Estimating the cost of caring for people with cancer at the end of life: A modelling study. Palliat Med 29(10):899–907CrossRef
36.
Zurück zum Zitat Liljas B (1998) How to calculate indirect costs in economic evaluations. Pharmacoeconomics 13:1–7CrossRef Liljas B (1998) How to calculate indirect costs in economic evaluations. Pharmacoeconomics 13:1–7CrossRef
37.
Zurück zum Zitat Krol M, Brouwer W, Rutten F (2013) Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics 31(7):537–549CrossRef Krol M, Brouwer W, Rutten F (2013) Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics 31(7):537–549CrossRef
38.
Zurück zum Zitat Krol M, Brouwer W (2014) How to estimate productivity costs in economic evaluations. Pharmacoeconomics 32(4):335–344CrossRef Krol M, Brouwer W (2014) How to estimate productivity costs in economic evaluations. Pharmacoeconomics 32(4):335–344CrossRef
39.
Zurück zum Zitat Hanly P, Pearce A, Sharp L (2014) The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Rev Pharmacoecon Outcomes Res 14(3):355–377CrossRef Hanly P, Pearce A, Sharp L (2014) The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Rev Pharmacoecon Outcomes Res 14(3):355–377CrossRef
40.
Zurück zum Zitat Koopmanschap MA, van Ineveld BM (1992) Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34:1005–1010CrossRef Koopmanschap MA, van Ineveld BM (1992) Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34:1005–1010CrossRef
Metadaten
Titel
Labour productivity loss caused by premature deaths associated with breast cancer: results from Spain over a 10-year period
verfasst von
J. Oliva-Moreno
L. M. Peña-Longobardo
Publikationsdatum
12.09.2018
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4963-z

Weitere Artikel der Ausgabe 3/2018

Breast Cancer Research and Treatment 3/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.